Clinical Study

Pycnogenol® Normalizes Cardio Risks During Perimenopause

Published

Format: PDF file | Document type: Clinical Study

Luzzi

Related categories: Cardiovascular health

A new study builds upon previous research showing the benefits of Pycnogenol®​ for alleviating perimenopause symptoms and is the first study to show effects on cardiovascular risk markers, homocysteine and CRP levels.

Daily Pycnogenol®​ supplementation reduced and normalized elevated cardiovascular risk factors often related to perimenopause: cholesterol, triglycerides, blood pressure and blood glucose. Participants also reported significant relief of hot flashes, reduction of night sweats and mood improvement.

Related resources from Horphag Research (USA) Inc.

Supplier info centre